Largest HRT Study: 10 Million Women Provide New Clarity on Longevity
A landmark study published in the journal Menopause (2024) has fundamentally shifted our understanding of Hormone Replacement Therapy (HRT) for women over 65. By analyzing the medical records of 10.3 million women—the largest data set ever examined for this purpose—researchers found that many long-held fears regarding hormone therapy may be unfounded.

Key Takeaways from the Research
The study compared women who continued or initiated HRT after age 65 against those who did not. The findings revealed significant protective benefits for those using estrogen:

Overall Longevity: Estrogen-only therapy was associated with a 19% to 21% reduction in the risk of death from all causes.

Cardiovascular Health: Users showed a lower risk of heart failure, heart attacks, and blood clots.

Cancer Risk: Estrogen-only therapy was linked to a lower risk of breast, lung, and colorectal cancers.

Brain Health: The data suggested a decreased risk of developing Alzheimer’s and other forms of dementia.

A Modern Approach to Aging
For decades, the medical community was guided by older, smaller studies that suggested HRT was too risky for older women. This new “10 Million Women” study suggests that for many, the protective benefits for the heart, brain, and bones can continue well into a woman’s senior years.

At the Florida Anti-Aging Center, we specialize in using this level of clinical evidence to help our patients navigate the complexities of hormone optimization. Dr. Raymond Adamcik, MD, and our team provide personalized evaluations to ensure your health strategy is based on the most current science available.

Ready to discuss your health goals? To learn more about how this research applies to your personal wellness plan, contact us: 📞 321-690-0003 📍 Florida Anti-Aging Center